GLP-1 agonists have proven highly effective in managing type 2 diabetes and related metabolic disorders, offering benefits such as improved glycemic control, weight loss, enhanced cardiovascular and renal health, and potential neuroprotective effects. This evidence concerns the gene GCG and metabolic disease.